{{Rsnum
|rsid=1625895
|Gene=TP53
|Chromosome=17
|position=7674797
|Orientation=minus
|GMAF=0.1373
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=TP53
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 20.4 | 79.6
| HCB | 0.0 | 5.8 | 94.2
| JPT | 0.0 | 0.9 | 99.1
| YRI | 8.2 | 46.3 | 45.6
| ASW | 7.0 | 38.6 | 54.4
| CHB | 0.0 | 5.8 | 94.2
| CHD | 0.0 | 9.2 | 90.8
| GIH | 5.9 | 36.6 | 57.4
| LWK | 13.6 | 43.6 | 42.7
| MEX | 0.0 | 12.1 | 87.9
| MKK | 16.0 | 48.1 | 35.9
| TSI | 2.9 | 26.5 | 70.6
| HapMapRevision=28
}}
*{{PMID|19193430}} [[rs2279744]], [[rs1042522]], [[rs17878362]] and [[rs1625895]] associated with high grade [[endometrial cancer]]

{{PMID Auto
|PMID=19505915
|Title=Association of Genetic Polymorphisms, mRNA Expression of p53 and p21 with Chronic Benzene Poisoning in a Chinese Occupational Population
}}

{{PMID Auto
|PMID=21838531
|Title=Crosstalk between the FGFR2 and TP53 genes in breast cancer: data from an association study and epistatic interaction analysis
}}

{{PMID Auto
|PMID=22829776
|Title=A Genome-Wide Association Meta-Analysis of Circulating Sex Hormone–Binding Globulin Reveals Multiple Loci Implicated in Sex Steroid Hormone Regulation
|OA=1
}}

{{PMID Auto
|PMID=12466288
|Title=Haplotype and linkage disequilibrium architecture for human cancer-associated genes.
|OA=1
}}

{{PMID Auto
|PMID=16465622
|Title=Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.
|OA=1
}}

{{PMID Auto
|PMID=17151932
|Title=Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma.
}}

{{PMID Auto
|PMID=17301252
|Title=Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors.
}}

{{PMID Auto
|PMID=17428325
|Title=Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=17449902
|Title=Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
}}

{{PMID Auto
|PMID=17624591
|Title=Genetic variation of TP53, polycyclic aromatic hydrocarbon-related exposures, and breast cancer risk among women on Long Island, New York.
}}

{{PMID Auto
|PMID=17908995
|Title=Genetic variants in cell cycle control pathway confer susceptibility to lung cancer.
}}

{{PMID Auto
|PMID=18640487
|Title=Association of donor inflammation- and apoptosis-related genotypes and delayed allograft function after kidney transplantation.
|OA=1
}}

{{PMID Auto
|PMID=18798306
|Title=Construction of a high resolution linkage disequilibrium map to evaluate common genetic variation in TP53 and neural tube defect risk in an Irish population.
|OA=1
}}

{{PMID Auto
|PMID=18854777
|Title=Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy.
|OA=1
}}

{{PMID Auto
|PMID=19276285
|Title=Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer.
|OA=1
}}

{{PMID Auto
|PMID=19276375
|Title=Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.
|OA=1
}}

{{PMID Auto
|PMID=19423538
|Title=Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited.
|OA=1
}}

{{PMID Auto
|PMID=19426493
|Title=A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population.
|OA=1
}}

{{PMID Auto
|PMID=21810023
|Title=Coordination of TP53 abnormalities in breast cancer: data from analysis of TP53 polymorphisms, loss of heterozygosity, methylation, and mutations.
}}

{{PMID Auto
|PMID=23360829
|Title=Association between polymorphisms in the genes for tumor suppressor protein p53 and its regulator NAD(P)H: quinone oxidoreductase 1 (NQO1) and schizophrenia in a Syrian study cohort
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}